FluMist approved for self-administration in the US - astrazeneca.com
WEB2 days ago · FluMist has been approved in the US as the only self-administered influenza vaccine.FluMist, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or administered by a parent/caregiver to individuals 2-17 years of age. 1. The approval by the US Food and Drug Administration (FDA) was based on a comprehensive submission, which included results from a ...
FDA approves first flu vaccine that can be self-administered at …
WEB2 days ago · Link Copied! The FDA approved FluMist as the first flu vaccine that can be self-administered at home. Sarah Silbiger/Getty Images. The US Food and Drug Administration on Friday approved the first ...
FDA approves first self-administered flu vaccine spray - CBS News
WEB2 days ago · The FDA approved AstraZeneca's FluMist flu vaccine spray for self-administered use at home. ... Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers the ...
Nasal Flu Vaccine Is Approved for At-Home Use - The New York …
WEB3 days ago · Sept. 20, 2024, 2:46 p.m. ET. The Food and Drug Administration on Friday authorized at-home use of FluMist, opening the door for needle-shy people to have easy access to a nasal spray vaccine that ...
FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver ...
WEB2 days ago · FluMist is approved for the prevention of influenza disease caused by influenza virus subtypes A and B in individuals 2 through 49 years of age. FluMist is sprayed into the nose and has been used ...
FLUMIST approved for self-administration in the US
WEB2 days ago · Iskra Reic, Executive Vice President, Vaccines and Immune Therapies, AstraZeneca, said: “The approval of FLUMIST for self-administration is an important step forward in making vaccines more ...
US FDA Approves AstraZeneca's Self-Administered Nasal Spray ... - U.S. News
WEB2 days ago · (Reuters) -The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for self-administration, making it the first of its kind. FluMist is the first ...
US Food and Drug Administration accepts for review AstraZeneca…
WEBOct 24, 2023 · AstraZeneca’s Supplemental Biologics License Application (sBLA) for the approval of a self- or caregiver-administered option for FluMist Quadrivalent, a needle-free nasal spray, has been accepted for review by the US Food and Drug Administration (FDA). If approved, FluMist will be the first flu vaccine available to be self-administered by eligible patients or administered by caregivers ...
FLUMIST® QUADRIVALENT (Influenza Vaccine Live ... - AstraZeneca US
WEBSep 23, 2022 · AstraZeneca announces FLUMIST ® QUADRIVALENT (Influenza Vaccine Live, Intranasal) doses are now available in the US for the 2022-2023 influenza season. FLUMIST QUADRIVALENT, the only Food and Drug Administration (FDA)-approved nasal-spray flu vaccine, is indicated for people ages 2 through 49. 1.
US FDA approves AstraZeneca's self-administered nasal spray flu …
WEB2 days ago · Sept 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's (AZN.L) nasal spray flu vaccine for self-administration, making it the first of its kind ...